Medtronic leads $37M investment in ablation mapping startup CoreMap
Xeltis has raised an additional €20.5m to expand its vascular implant programmes in Europe and the US.
Cambridge-based health tech company Qureight has secured £15m in Series B funding to expand its AI-powered clinical trial imaging platform.
UK specialty pharma Pharmanovia has licensed senaparib, IMPACT Therapeutics’ oral PARP1/2 inhibitor, across 66 countries in a deal worth up to €423.5 million.
Berlin-based Pentixapharm Holding AG has raised about €20.4 million to fund a pivotal Phase 3 trial of its PET diagnostic PentixaFor and advance its CXCR4-targeted theranostics pipeline.
Apnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch
GSK is boosting its AI chops with a new deal worth up to $110 million with Relation.
The private equity arm of Goldman Sachs has agreed to acquire control of Italian medical equipment maker Numantec from White Bridge Investment
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.